Charles River Laboratories Intl. Inc (N:CRL)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CRL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 15th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 8/22 Aug 5/22 LaPlume Joseph W Direct Ownership Common Stock S - Open market or private sale -200 $226.13
Aug 8/22 Jul 6/22 LaPlume Joseph W Direct Ownership Common Stock G - Gift -195  
Jun 1/22 May 29/22 Foster James C Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,311 $244.41
Jun 1/22 May 29/22 Barbo William D Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -202 $244.41
May 31/22 May 29/22 LaPlume Joseph W Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -223 $244.41
May 31/22 May 29/22 Girshick Birgit Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -218 $244.41
May 31/22 May 29/22 Knell Michael Gunnar Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -54 $244.41
May 31/22 May 29/22 Creamer Victoria L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -190 $244.41
Jun 1/22 May 28/22 Barbo William D Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -112 $244.41
May 31/22 May 28/22 LaPlume Joseph W Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -125 $244.41
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CRL within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 15th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 8/22 Aug 5/22 LaPlume Joseph W Direct Ownership Common Stock S - Open market or private sale -200 $226.13
Aug 8/22 Jul 6/22 LaPlume Joseph W Direct Ownership Common Stock G - Gift -195  
Jun 1/22 May 27/22 Foster James C Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,042 $244.41
Jun 1/22 May 29/22 Foster James C Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,311 $244.41
Jun 1/22 May 27/22 Pease Flavia Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 4,423 $244.41
Jun 1/22 May 27/22 Pease Flavia Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,637  
Jun 1/22 May 27/22 Barbo William D Direct Ownership Stock Options (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 4,036 $244.41
Jun 1/22 May 29/22 Barbo William D Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -202 $244.41
Jun 1/22 May 28/22 Barbo William D Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -112 $244.41
Jun 1/22 May 27/22 Barbo William D Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,493  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CRL

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
United Therapeutics (OQ:UTHR)
Revolution Medicines (OQ:RVMD)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.